Refine Results
  1. "Martin Tallman"
Formats
  1. Journal Article (286)
  2. Meeting Abstract (254)
  3. Book Section (7)
  4. Editorial (3)
  5. Guidelines (3)
  6. Review (3)
  7. Research Letter (2)
  8. Correspondence (1)
Groups
  1. Adult Leukemia (559)
  2. Center for Hematologic Malignancies (559)
  3. Hematologic Malignancies, Division of (370)
  4. Hematologic Oncology, Division of (189)
  5. GSK Faculty (140)
  6. Human Oncology and Pathogenesis Program (132)

More Groups

People
  1. Martin Tallman (559)
  2. Ross Levine (111)
  3. Eytan Stein (97)
  4. Jae Park (66)
  5. Sean Devlin (58)
  6. Omar Abdel-Wahab (54)

More People

Years
  1. 2021 (11)
  2. 2020 (41)
  3. 2019 (63)
  4. 2018 (63)
  5. 2017 (61)
  6. 2016 (64)

More Years

Publications
  1. Blood (238)
  2. Journal of Clinical Oncology (37)
  3. Leukemia Research (24)
  4. Haematologica (21)
  5. Leukemia and Lymphoma (19)
  6. Blood Advances (18)

More Publications

Publishers
  1. American Society of Hematology (256)
  2. Elsevier Inc. (38)
  3. American Society of Clinical Oncology (37)
  4. Nature Publishing Group (31)
  5. Elsevier Ltd (23)
  6. Ferrata Storti Foundation (21)

More Publishers

Results (559)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Incorporation of novel therapies for the treatment of acute myeloid leukemia: A perspective
    Review

    Waksal, J. A.; Tallman, M. S.
    Leukemia and Lymphoma (2021)

    Fulltext@MSK | Save
  • BL-8040 CXCR4 antagonist is safe and demonstrates antileukemic activity in combination with cytarabine for the treatment of relapsed/refractory acute myelogenous leukemia: An open-label safety and efficacy phase 2a study
    Journal Article

    Borthakur, G.; Ofran, Y.; Tallman, M. S.; Foran, J.; Uy, G. L.; DiPersio, J. F.; Showel, M. M.; Shimoni, A.; Nagler, A.; Rowe, J. M.; more...
    Cancer (2021)

    Fulltext@MSK | Save
  • The prognosis and durable clearance of RAS mutations in patients with acute myeloid leukemia receiving induction chemotherapy
    Research Letter

    Ball, B. J.; Hsu, M.; Devlin, S. M.; Arcila, M.; Roshal, M.; Zhang, Y.; Famulare, C. A.; Goldberg, A. D.; Cai, S. F.; Dunbar, A.; more...
    American Journal of Hematology (2021)

    Fulltext@MSK | Save
  • Arsenic trioxide therapy predisposes to herpes zoster reactivation despite minimally myelosuppressive therapy
    Journal Article

    Glass, J. L.; Derkach, A.; Hilden, P.; King, A.; Seo, S. K.; Ahr, K.; Kishtagari, A.; Levine, R. L.; Tallman, M. S.; Douer, D.
    Leukemia Research (2021)

    Fulltext@MSK | Save
  • Lenalidomide-epoetin alfa versus lenalidomide monotherapy in myelodysplastic syndromes refractory to recombinant erythropoietin
    Journal Article

    List, A. F.; Sun, Z.; Verma, A.; Bennett, J. M.; Komrokji, R. S.; McGraw, K.; Maciejewski, J.; Altman, J. K.; Cheema, P. S.; Claxton, D. F.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Clinical and molecular predictors of response and survival following venetoclax therapy in relapsed/refractory AML
    Journal Article

    Stahl, M.; Menghrajani, K.; Derkach, A.; Chan, A.; Xiao, W.; Glass, J.; King, A. C.; Daniyan, A. F.; Famulare, C.; Cuello, B. M.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Hematopoietic cell transplantation in the treatment of newly diagnosed adult acute myeloid leukemia: An evidence-based review from the American Society of Transplantation and Cellular Therapy
    Guidelines

    Dholaria, B.; Savani, B. N.; Hamilton, B. K.; Oran, B.; Liu, H. D.; Tallman, M. S.; Ciurea, S. O.; Holtzman, N. G.; Phillips, G. L. 2nd; Devine, S. M.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Comparison of CALGB 10403 (Alliance) and COG AALL0232 toxicity results in young adults with acute lymphoblastic leukemia
    Journal Article

    Advani, A. S.; Larsen, E.; Laumann, K.; Luger, S. M.; Liedtke, M.; Devidas, M.; Chen, Z.; Yin, J.; Foster, M. C.; Claxton, D.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Triggering interferon signaling in T cells with avadomide sensitizes CLL to anti-PD-L1/PD-1 immunotherapy
    Journal Article

    Ioannou, N.; Hagner, P. R.; Stokes, M.; Gandhi, A. K.; Apollonio, B.; Fanous, M.; Papazoglou, D.; Sutton, L. A.; Rosenquist, R.; Amini, R. M.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Tolerability and toxicity of pegaspargase in adults 40 years and older with acute lymphoblastic leukemia
    Journal Article

    Daley, R. J.; Rajeeve, S.; Kabel, C. C.; Pappacena, J. J.; Stump, S. E.; Lavery, J. A.; Tallman, M. S.; Geyer, M. B.; Park, J. H.
    Leukemia and Lymphoma (2021)

    Fulltext@MSK | Save